Ticker
STOKCompany Name
STOKE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 61.6M | 30.81% | $ 199.89M |
3/31/2025 | $ 69.54M | 36.43% | $ 190.91M |
12/31/2024 | $ -86.85M | -237.59% | $ 36.55M |
9/30/2024 | $ -84.31M | -503.54% | $ 16.74M |
6/30/2024 | $ -79.95M | -527.51% | $ 15.16M |
3/31/2024 | $ -84.28M | -1074.28% | $ 7.84M |
12/31/2023 | $ -81.07M | -923.31% | $ 8.78M |
9/30/2023 | $ -82.79M | -895.33% | $ 9.25M |
6/30/2023 | $ -87.58M | -990.33% | $ 8.84M |
3/31/2023 | $ -85.71M | -588.85% | $ 14.56M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for STOKE THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -41.49M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Mar 31, 2024
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |